Samsung Medical Center
Uterine cancer treatment cost in South Korea typically includes essential diagnostics like a PET/CT scan from AUD $1,435 to AUD $2,153. Surgical options like a hysterectomy with DaVinci robot run from AUD $16,506 to AUD $26,983, while a laparoscopic hysterectomy ranges from AUD $16,506 to AUD $27,988. Total expenses depend on the cancer stage and hospital choice. Patients often save approximately 30–50% compared to private healthcare costs in Australia. Most international treatment centres are located in Seoul and Incheon.
Typical Uterine Cancer Treatment Costs in South Korea
Bookimed Expert Insight: Patients seeking aesthetic results should consider Ewha Womans University Medical Center. They focus on small incisions to avoid visible scars. For complex oncology cases, Asan Medical Center is the largest facility in South Korea. It handles over 2,500 inpatients daily. Samsung Medical Center holds Newsweek rankings and uses AI to assist in robotic surgeries. This helps surgeons maintain high accuracy during complex removals.
| Republic of Korea | Thailand | Turkey | |
| Laparoscopic Hysterectomy | from AUD $16,506 | from AUD $10,764 | from AUD $6,459 |
| Hysterectomy (uterus removal) | from AUD $7,176 | from AUD $4,484 | from AUD $6,832 |
| Hormone therapy | from AUD $2,871 | from AUD $2,583 | from AUD $573 |
| Hysterectomy with DaVinci robot | from AUD $16,506 | from AUD $15,788 | from AUD $15,788 |
| Radiotherapy for uterine cancer | from AUD $24,400 | - | from AUD $5,741 |
No hidden fees – just official clinic prices. Pay at the clinic for Uterine cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Uterine cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Uterine cancer treatment journey.
Professor Lee Kwang Beom specialises in treating uterine cancer through laparoscopic surgery – a minimally invasive approach using small incisions for less scarring and quicker healing.
Professor Kim Sung Hun is a specialist oncogynecologist at Severance Hospital with a focus on minimally invasive surgery for uterine oncology.
Professor Kim Young Tae leads the Women's Cancer Centre at Severance Hospital – a facility recognised for early adoption of robotic surgical systems.
Uterine cancer treatment in South Korea achieves high results. For endometrial cancer, 5-year relative survival rates reach 88% to 91%. Major Seoul centres report regional stage survival at 77%. Outcomes are supported by robotic surgery and multidisciplinary oncology units at JCI-accredited facilities.
Bookimed Expert Insight: South Korea's leadership in robotic surgery is distinct. Ewha Womans University Medical Center was the first globally to perform single-incision robotic gynaecological surgery. This technique reduces scarring and helps patients recover faster. For Australians, choosing a centre like Seoul National University Hospital provides access to outcomes that statistically beat international averages. For example, the hospital's breast cancer survival rate is 91.9%.
Patient Consensus: Patients note that early-stage uterine cancer is often treated successfully. Many report long-term remission after surgery and adjuvant care. In the Republic of Korea, doctors are highly receptive to providing second opinions. This is especially true for complex cases.
Robotic surgery and minimally invasive techniques are common for uterine cancer in South Korea. Major Seoul hospitals use these methods in approximately 90% of early-stage cases. Facilities often employ the da Vinci robotic system. This approach offers faster recovery and involves smaller incisions compared to open surgery.
Bookimed Expert Insight: Robotic surgery is widespread in South Korea. However, Korean specialists like Dr Kim Young Tae at Severance Hospital focus on specific case suitability. Data shows clinics such as Korea University Anam Hospital offer same-day diagnostic pathways. This lets international patients confirm their eligibility for robotic treatment within 24 hours of arrival.
Patient Consensus: Patients note that Korean care involves a full surgical work-up including hospital stays and pathology. They suggest confirming the surgeon's specific experience with minimally invasive cancer cases before arrival.
South Korean oncology centres offer fertility-sparing treatments for early-stage uterine cancer. These include high-dose hormone therapy and robotic surgery. Specialists often combine progestins with egg freezing to protect reproductive options. Most clinics facilitate rapid oncofertility referrals to start preservation before intensive treatment begins.
Bookimed Expert Insight: Most international patients focus on Seoul. However, Ewha Womans University Medical Center offers a distinct advantage as a women-only facility. They were first globally to perform single-incision robotic gynaecological surgery. Our data shows this approach significantly reduces scarring and recovery time. This is an improvement over traditional multi-port robotic systems.
Patient Consensus: Patients in South Korea stress seeking an oncofertility referral immediately. This helps avoid treatment delays. They often note that if a hysterectomy becomes necessary later, freezing eggs remains a vital step. This step supports future surrogacy paths.
South Korean treatment for uterine cancer involves minimally invasive surgery. It also includes precision radiation and targeted therapy. Specialist centres focus on laparoscopic-assisted staging and robotic surgery for early-stage cases. These methods reduce pain and speed up recovery. Doctors use genetic testing to select specific immunotherapy drugs for advanced stages.
Bookimed Expert Insight: South Korean clinics report high success rates for gynaecological cancers. This is because they integrate oncology and fertility. Centres like Asan Medical Center handle vast patient volumes. This density allows surgeons to specialise exclusively in robotic gynaecological oncology rather than general surgery. This specialisation leads to faster procedures and fewer hospital nights.
Patient Consensus: Patients note the speed of diagnosis in South Korea is exceptional. They often complete scans and consult specialists within days of arriving. The bedside manner is warm, and the high-tech facilities make recovery feel much more comfortable.
Korean doctors treat uterine cancer based on stage and tumour biology. Early cases often involve robotic or laparoscopic hysterectomies. Advanced cases require multimodal plans. These include cytoreductive surgery, platinum-based chemotherapy, and immunotherapy. Specialists at JCI-accredited Seoul centres manage high-risk cases with concurrent chemoradiotherapy.
Bookimed Expert Insight: Major Seoul centres like Samsung Medical Center and Severance Hospital operate as high-volume hubs. Severance alone performs over 4,000 robotic procedures. This high volume lets Korean oncologists refine techniques for stage 1B grade 2 cases. These cases often receive intensive radiation and inpatient chemotherapy. These protocols are typically reserved for more advanced stages elsewhere.
Patient Consensus: Patients note that Korean specialists often start with surgery to finalise staging. They value the rapid transition to chemotherapy or immunotherapy when pathology shows high-risk features.
Uterine cancer patients in South Korea require regular follow-up care to monitor for recurrence. Surveillance typically lasts for 5 years. Standard protocols include physical exams and pelvic reviews every 3 to 6 months initially. Specialists individualise these schedules based on cancer stage and surgical approach.
Bookimed Expert Insight: South Korea ranks 8th globally for medical requests. However, its oncology centres offer unique surgical density. Clinics like Samsung Medical Center and Asan Medical Center perform over 45,000 surgeries annually. This high volume allows surgeons to refine follow-up protocols. They can then tailor them for specific uterine cancer subtypes. JCI-accredited facilities, such as Ewha Womans University Medical Center, often provide integrated digital systems. These systems allow Australian GPs to access real-time CT and MRI images. This enables seamless local follow-up.
Patient Consensus: Patients note that Korean hospitals provide detailed pathology and scan reports to bring home. They often suggest staying a few days after chemotherapy to recuperate. This helps before the long flight back to Australia.
Uterine cancer treatment in South Korea typically takes 2 to 3 weeks. This includes surgery and recovery. If chemotherapy or radiation is required, the timeline extends to 4 to 5 months. Patients often return home 14 days after surgery once immediate post-operative checks are complete.
Bookimed Expert Insight: While many patients focus on surgery, South Korea's real efficiency lies in the diagnostic phase. Major centres like Severance Hospital and Asan Medical Center handle over 45,000 surgeries annually. This volume allows them to produce final pathology reports in just 7 days. Australian patients can save weeks of waiting compared to domestic public health systems. One specific package at Seoul Miz Hospital includes hyperbaric oxygen therapy. This helps speed up wound healing.
Patient Consensus: Patients note that cancer treatment is measured in weeks. However, the system moves rapidly once diagnostic scans are submitted. They emphasise that chemotherapy cycles can last months. However, the hospital's translation support and coordination make managing the long timeline much easier.